 Emily Farrow
Concepts (391)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| High-Throughput Nucleotide Sequencing | 13 | 2023 | 94 | 2.700 |
Why?
| | Fibroblast Growth Factors | 13 | 2018 | 27 | 2.480 |
Why?
| | Mutation | 16 | 2023 | 194 | 1.870 |
Why?
| | Familial Hypophosphatemic Rickets | 5 | 2014 | 9 | 1.560 |
Why?
| | Humans | 69 | 2024 | 6599 | 1.520 |
Why?
| | Genetic Variation | 7 | 2020 | 161 | 1.150 |
Why?
| | Sequence Analysis, DNA | 11 | 2023 | 106 | 1.050 |
Why?
| | Phenotype | 17 | 2022 | 233 | 1.000 |
Why?
| | Genetic Predisposition to Disease | 7 | 2020 | 215 | 0.950 |
Why?
| | Genetic Testing | 9 | 2022 | 74 | 0.910 |
Why?
| | Genome, Human | 7 | 2022 | 82 | 0.890 |
Why?
| | Genes, Recessive | 5 | 2017 | 6 | 0.870 |
Why?
| | Kidney | 5 | 2012 | 89 | 0.850 |
Why?
| | Medicine | 1 | 2021 | 10 | 0.810 |
Why?
| | Phosphates | 6 | 2014 | 13 | 0.760 |
Why?
| | Calcinosis | 4 | 2018 | 6 | 0.760 |
Why?
| | Glucuronidase | 5 | 2012 | 5 | 0.730 |
Why?
| | Alleles | 10 | 2024 | 197 | 0.730 |
Why?
| | Male | 28 | 2022 | 3197 | 0.730 |
Why?
| | Abnormalities, Multiple | 6 | 2018 | 36 | 0.720 |
Why?
| | Mutation, Missense | 7 | 2018 | 24 | 0.710 |
Why?
| | Dental Enamel Proteins | 1 | 2019 | 1 | 0.710 |
Why?
| | Hypophosphatemia | 4 | 2011 | 5 | 0.700 |
Why?
| | Female | 31 | 2022 | 3436 | 0.680 |
Why?
| | Extracellular Matrix Proteins | 3 | 2011 | 13 | 0.680 |
Why?
| | Rare Diseases | 3 | 2024 | 37 | 0.650 |
Why?
| | Phosphoproteins | 2 | 2008 | 11 | 0.650 |
Why?
| | Genomics | 3 | 2024 | 86 | 0.640 |
Why?
| | Intellectual Disability | 4 | 2022 | 31 | 0.630 |
Why?
| | Laboratories | 3 | 2022 | 16 | 0.620 |
Why?
| | Exome | 11 | 2022 | 34 | 0.590 |
Why?
| | Bone Diseases, Metabolic | 1 | 2016 | 8 | 0.590 |
Why?
| | Glucuronosyltransferase | 1 | 2016 | 16 | 0.590 |
Why?
| | Developmental Disabilities | 4 | 2020 | 38 | 0.580 |
Why?
| | Fractures, Bone | 1 | 2016 | 35 | 0.580 |
Why?
| | Child, Preschool | 16 | 2020 | 1459 | 0.570 |
Why?
| | Animals | 13 | 2021 | 563 | 0.560 |
Why?
| | Bone and Bones | 5 | 2017 | 16 | 0.560 |
Why?
| | MAP Kinase Signaling System | 3 | 2018 | 5 | 0.530 |
Why?
| | N-Acetylgalactosaminyltransferases | 3 | 2011 | 4 | 0.520 |
Why?
| | Child | 21 | 2023 | 3146 | 0.500 |
Why?
| | Mice | 10 | 2021 | 290 | 0.500 |
Why?
| | Base Sequence | 6 | 2023 | 76 | 0.460 |
Why?
| | Hyperphosphatemia | 4 | 2018 | 10 | 0.430 |
Why?
| | Nervous System Malformations | 2 | 2022 | 6 | 0.410 |
Why?
| | Genetic Diseases, Inborn | 3 | 2018 | 18 | 0.410 |
Why?
| | Epilepsy | 3 | 2016 | 14 | 0.400 |
Why?
| | Mitochondrial Diseases | 3 | 2017 | 3 | 0.400 |
Why?
| | Pedigree | 7 | 2023 | 53 | 0.390 |
Why?
| | Cleft Lip | 3 | 2021 | 5 | 0.380 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2010 | 4 | 0.380 |
Why?
| | Cleft Palate | 3 | 2021 | 8 | 0.380 |
Why?
| | Wnt Proteins | 1 | 2010 | 11 | 0.380 |
Why?
| | Cell Line | 5 | 2018 | 80 | 0.380 |
Why?
| | Autistic Disorder | 2 | 2022 | 12 | 0.380 |
Why?
| | Infant | 14 | 2023 | 1396 | 0.370 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2009 | 3 | 0.370 |
Why?
| | Kidney Tubules, Distal | 1 | 2009 | 1 | 0.350 |
Why?
| | Sodium-Phosphate Cotransporter Proteins | 1 | 2009 | 1 | 0.350 |
Why?
| | Genome-Wide Association Study | 3 | 2020 | 181 | 0.340 |
Why?
| | Recombinant Proteins | 3 | 2016 | 47 | 0.330 |
Why?
| | Signal Transduction | 4 | 2018 | 107 | 0.310 |
Why?
| | Infant, Newborn | 10 | 2021 | 790 | 0.300 |
Why?
| | Immunologic Deficiency Syndromes | 2 | 2018 | 8 | 0.300 |
Why?
| | Chromosome Mapping | 2 | 2024 | 33 | 0.290 |
Why?
| | Genotype | 5 | 2022 | 395 | 0.290 |
Why?
| | Bone Diseases, Developmental | 1 | 2006 | 3 | 0.280 |
Why?
| | DNA Mutational Analysis | 6 | 2017 | 36 | 0.280 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 76 | 0.270 |
Why?
| | Brain | 5 | 2018 | 74 | 0.270 |
Why?
| | DNA | 3 | 2019 | 39 | 0.260 |
Why?
| | Heterozygote | 4 | 2018 | 23 | 0.240 |
Why?
| | Diverticulitis | 1 | 2023 | 1 | 0.230 |
Why?
| | Diverticulitis, Colonic | 1 | 2023 | 1 | 0.230 |
Why?
| | Ameloblastoma | 1 | 2023 | 2 | 0.230 |
Why?
| | Odontogenic Tumors | 1 | 2023 | 2 | 0.230 |
Why?
| | Retrospective Studies | 4 | 2023 | 1251 | 0.230 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2023 | 2 | 0.230 |
Why?
| | Genetic Association Studies | 3 | 2021 | 53 | 0.230 |
Why?
| | Adolescent | 9 | 2020 | 2087 | 0.230 |
Why?
| | Insurance Coverage | 1 | 2023 | 19 | 0.220 |
Why?
| | Neurodevelopmental Disorders | 1 | 2022 | 19 | 0.220 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 27 | 0.220 |
Why?
| | DNA Methylation | 1 | 2023 | 108 | 0.220 |
Why?
| | Cytochrome P-450 CYP2C8 | 1 | 2022 | 3 | 0.210 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2022 | 25 | 0.210 |
Why?
| | Codon, Nonsense | 2 | 2019 | 6 | 0.210 |
Why?
| | Osteocytes | 2 | 2011 | 3 | 0.210 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2022 | 54 | 0.210 |
Why?
| | Gene Expression Regulation | 2 | 2022 | 98 | 0.200 |
Why?
| | Frameshift Mutation | 2 | 2013 | 5 | 0.200 |
Why?
| | Molecular Sequence Annotation | 1 | 2021 | 9 | 0.200 |
Why?
| | Diagnostic Tests, Routine | 2 | 2018 | 17 | 0.200 |
Why?
| | Herpes Simplex | 1 | 2020 | 10 | 0.200 |
Why?
| | Infant, Premature, Diseases | 1 | 2021 | 23 | 0.190 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2020 | 26 | 0.190 |
Why?
| | Microfilament Proteins | 1 | 2020 | 12 | 0.190 |
Why?
| | Sexual Development | 1 | 2020 | 2 | 0.190 |
Why?
| | Karyotyping | 1 | 2020 | 8 | 0.190 |
Why?
| | eIF-2 Kinase | 1 | 2020 | 1 | 0.190 |
Why?
| | Disorders of Sex Development | 1 | 2020 | 9 | 0.190 |
Why?
| | Leukoencephalopathies | 1 | 2020 | 2 | 0.190 |
Why?
| | RNA Polymerase III | 2 | 2018 | 2 | 0.190 |
Why?
| | Protein Structure, Tertiary | 2 | 2011 | 14 | 0.180 |
Why?
| | Genome | 2 | 2022 | 30 | 0.180 |
Why?
| | Autism Spectrum Disorder | 1 | 2020 | 26 | 0.180 |
Why?
| | Sequence Deletion | 2 | 2016 | 8 | 0.180 |
Why?
| | RNA, Messenger | 4 | 2015 | 107 | 0.180 |
Why?
| | Blood | 1 | 2019 | 10 | 0.180 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2021 | 67 | 0.180 |
Why?
| | Dental Enamel | 1 | 2019 | 1 | 0.180 |
Why?
| | Goldenhar Syndrome | 1 | 2019 | 1 | 0.180 |
Why?
| | Dental Care | 1 | 2019 | 2 | 0.180 |
Why?
| | Hemophilia A | 1 | 2019 | 15 | 0.180 |
Why?
| | Ectodermal Dysplasia | 2 | 2018 | 2 | 0.170 |
Why?
| | Pregnancy | 5 | 2020 | 203 | 0.170 |
Why?
| | Hyperostosis, Cortical, Congenital | 1 | 2018 | 2 | 0.170 |
Why?
| | Autoimmune Diseases | 1 | 2018 | 11 | 0.170 |
Why?
| | Autoantibodies | 1 | 2018 | 9 | 0.170 |
Why?
| | Premature Birth | 1 | 2018 | 5 | 0.170 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2018 | 4 | 0.170 |
Why?
| | Tuberous Sclerosis | 1 | 2018 | 4 | 0.170 |
Why?
| | Mice, Knockout | 3 | 2017 | 54 | 0.170 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2018 | 2 | 0.160 |
Why?
| | Genes, Dominant | 1 | 2018 | 4 | 0.160 |
Why?
| | Cerebellar Ataxia | 1 | 2018 | 4 | 0.160 |
Why?
| | Megalencephaly | 1 | 2018 | 3 | 0.160 |
Why?
| | I-kappa B Kinase | 1 | 2018 | 4 | 0.160 |
Why?
| | Optic Atrophy | 1 | 2018 | 1 | 0.160 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2018 | 1 | 0.160 |
Why?
| | Spinocerebellar Ataxias | 1 | 2018 | 1 | 0.160 |
Why?
| | Mitochondria | 2 | 2015 | 9 | 0.160 |
Why?
| | Phosphotransferases | 1 | 2017 | 2 | 0.160 |
Why?
| | Muscle Hypotonia | 1 | 2017 | 6 | 0.160 |
Why?
| | Transcription Factors | 2 | 2018 | 46 | 0.160 |
Why?
| | Bone Marrow | 1 | 2017 | 6 | 0.160 |
Why?
| | Dwarfism | 2 | 2008 | 4 | 0.160 |
Why?
| | Myoclonic Epilepsies, Progressive | 1 | 2017 | 2 | 0.160 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2017 | 6 | 0.160 |
Why?
| | Erythropoietin | 1 | 2017 | 18 | 0.160 |
Why?
| | Peptide Elongation Factors | 1 | 2017 | 1 | 0.160 |
Why?
| | Ribonucleoprotein, U5 Small Nuclear | 1 | 2017 | 1 | 0.160 |
Why?
| | Mandibulofacial Dysostosis | 1 | 2017 | 2 | 0.150 |
Why?
| | Seizures | 1 | 2017 | 23 | 0.150 |
Why?
| | Alkyl and Aryl Transferases | 1 | 2017 | 2 | 0.150 |
Why?
| | Dextromethorphan | 1 | 2017 | 55 | 0.150 |
Why?
| | Protein Folding | 1 | 2016 | 2 | 0.150 |
Why?
| | Tubulin | 1 | 2016 | 4 | 0.150 |
Why?
| | Microtubules | 1 | 2016 | 5 | 0.150 |
Why?
| | Microtubule-Associated Proteins | 1 | 2016 | 5 | 0.150 |
Why?
| | Progeria | 1 | 2016 | 1 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2016 | 2 | 0.150 |
Why?
| | Brain Diseases | 1 | 2016 | 6 | 0.150 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2015 | 31 | 0.140 |
Why?
| | Cadherins | 1 | 2016 | 6 | 0.140 |
Why?
| | Mosaicism | 1 | 2016 | 8 | 0.140 |
Why?
| | Adult | 6 | 2018 | 1233 | 0.140 |
Why?
| | Yersinia Infections | 1 | 2015 | 1 | 0.140 |
Why?
| | Lymphadenitis | 1 | 2015 | 3 | 0.140 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2015 | 3 | 0.140 |
Why?
| | Shab Potassium Channels | 1 | 2015 | 1 | 0.140 |
Why?
| | Vertebrates | 1 | 2015 | 1 | 0.140 |
Why?
| | Body Patterning | 1 | 2015 | 1 | 0.140 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2015 | 1 | 0.140 |
Why?
| | Heterotaxy Syndrome | 1 | 2015 | 1 | 0.140 |
Why?
| | Point Mutation | 1 | 2015 | 4 | 0.140 |
Why?
| | Disease Models, Animal | 2 | 2018 | 55 | 0.130 |
Why?
| | Alstrom Syndrome | 1 | 2015 | 1 | 0.130 |
Why?
| | Parathyroid Hormone | 3 | 2010 | 24 | 0.130 |
Why?
| | DNA Polymerase II | 1 | 2015 | 1 | 0.130 |
Why?
| | DNA Breaks | 1 | 2015 | 2 | 0.130 |
Why?
| | Chromosomal Instability | 1 | 2015 | 2 | 0.130 |
Why?
| | Rats | 2 | 2014 | 97 | 0.130 |
Why?
| | Pneumonia, Aspiration | 1 | 2015 | 8 | 0.130 |
Why?
| | Group IV Phospholipases A2 | 1 | 2015 | 2 | 0.130 |
Why?
| | Polydactyly | 1 | 2015 | 1 | 0.130 |
Why?
| | Proteins | 1 | 2015 | 22 | 0.130 |
Why?
| | Syndactyly | 1 | 2015 | 4 | 0.130 |
Why?
| | Endopeptidase Clp | 1 | 2015 | 1 | 0.130 |
Why?
| | Metabolism, Inborn Errors | 1 | 2015 | 6 | 0.130 |
Why?
| | Group VI Phospholipases A2 | 1 | 2014 | 1 | 0.130 |
Why?
| | Neuroaxonal Dystrophies | 1 | 2014 | 2 | 0.130 |
Why?
| | Cytochrome P-450 CYP2D6 | 1 | 2017 | 180 | 0.130 |
Why?
| | Mice, Mutant Strains | 2 | 2014 | 7 | 0.130 |
Why?
| | Hypothalamic Diseases | 1 | 2013 | 1 | 0.120 |
Why?
| | Microphthalmos | 1 | 2013 | 1 | 0.120 |
Why?
| | Radius | 1 | 2013 | 1 | 0.120 |
Why?
| | Synostosis | 1 | 2013 | 1 | 0.120 |
Why?
| | Holoprosencephaly | 1 | 2013 | 1 | 0.120 |
Why?
| | Hamartoma | 1 | 2013 | 3 | 0.120 |
Why?
| | Mullerian Ducts | 1 | 2013 | 3 | 0.120 |
Why?
| | Femur | 1 | 2013 | 10 | 0.120 |
Why?
| | Middle Aged | 3 | 2023 | 648 | 0.120 |
Why?
| | Protein Transport | 2 | 2015 | 5 | 0.120 |
Why?
| | Pierre Robin Syndrome | 1 | 2013 | 5 | 0.120 |
Why?
| | Microcephaly | 1 | 2013 | 4 | 0.120 |
Why?
| | Genome, Mitochondrial | 1 | 2013 | 1 | 0.120 |
Why?
| | Facies | 3 | 2020 | 3 | 0.120 |
Why?
| | Lung | 1 | 2013 | 65 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2013 | 23 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2012 | 6 | 0.110 |
Why?
| | Models, Molecular | 2 | 2018 | 14 | 0.110 |
Why?
| | Radiography | 4 | 2015 | 38 | 0.110 |
Why?
| | Young Adult | 4 | 2018 | 652 | 0.110 |
Why?
| | Fibroblasts | 3 | 2018 | 26 | 0.110 |
Why?
| | Early Growth Response Protein 1 | 2 | 2009 | 2 | 0.110 |
Why?
| | Exons | 3 | 2022 | 32 | 0.110 |
Why?
| | Haplotypes | 2 | 2023 | 81 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 64 | 0.110 |
Why?
| | Osteomalacia | 1 | 2011 | 2 | 0.110 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2011 | 5 | 0.100 |
Why?
| | Gene-Environment Interaction | 1 | 2011 | 13 | 0.100 |
Why?
| | Nuclear Proteins | 2 | 2022 | 45 | 0.100 |
Why?
| | Mice, Transgenic | 1 | 2011 | 33 | 0.100 |
Why?
| | Syndrome | 3 | 2018 | 33 | 0.100 |
Why?
| | Magnetic Resonance Imaging | 3 | 2018 | 114 | 0.100 |
Why?
| | Receptor, Parathyroid Hormone, Type 1 | 1 | 2011 | 2 | 0.100 |
Why?
| | Nerve Tissue Proteins | 2 | 2023 | 24 | 0.100 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2010 | 1 | 0.100 |
Why?
| | DNA Copy Number Variations | 2 | 2022 | 31 | 0.090 |
Why?
| | Cell Cycle Proteins | 2 | 2022 | 15 | 0.090 |
Why?
| | Actins | 1 | 2009 | 5 | 0.090 |
Why?
| | DNA Primers | 1 | 2009 | 27 | 0.090 |
Why?
| | Hyperostosis | 1 | 2008 | 1 | 0.090 |
Why?
| | Subcellular Fractions | 1 | 2008 | 1 | 0.090 |
Why?
| | Conserved Sequence | 1 | 2008 | 5 | 0.090 |
Why?
| | Osteochondrodysplasias | 1 | 2008 | 3 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2008 | 5 | 0.080 |
Why?
| | Vitamin D | 1 | 2008 | 21 | 0.080 |
Why?
| | Bone Development | 1 | 2007 | 4 | 0.080 |
Why?
| | Calcification, Physiologic | 1 | 2007 | 3 | 0.080 |
Why?
| | Codon, Terminator | 1 | 2007 | 2 | 0.080 |
Why?
| | Chromosome Disorders | 1 | 2007 | 6 | 0.080 |
Why?
| | Aneuploidy | 1 | 2007 | 2 | 0.080 |
Why?
| | Chromosomes, Human, Pair 6 | 1 | 2007 | 4 | 0.080 |
Why?
| | Peptides | 1 | 2007 | 9 | 0.080 |
Why?
| | Ataxia | 2 | 2020 | 2 | 0.080 |
Why?
| | Zebrafish | 2 | 2018 | 6 | 0.080 |
Why?
| | Calcitriol | 3 | 2014 | 6 | 0.070 |
Why?
| | Homozygote | 2 | 2017 | 18 | 0.070 |
Why?
| | Craniosynostoses | 1 | 2006 | 1 | 0.070 |
Why?
| | Protein Conformation | 1 | 2006 | 4 | 0.070 |
Why?
| | Crystallography, X-Ray | 1 | 2006 | 4 | 0.070 |
Why?
| | NIH 3T3 Cells | 2 | 2017 | 4 | 0.070 |
Why?
| | Amino Acid Substitution | 2 | 2016 | 9 | 0.070 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2014 | 36 | 0.060 |
Why?
| | Formaldehyde | 1 | 2023 | 4 | 0.060 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2023 | 3 | 0.060 |
Why?
| | Genetic Heterogeneity | 1 | 2023 | 5 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2024 | 197 | 0.060 |
Why?
| | Survival of Motor Neuron 1 Protein | 1 | 2023 | 2 | 0.060 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2023 | 2 | 0.060 |
Why?
| | Sequence Analysis | 1 | 2023 | 3 | 0.060 |
Why?
| | Colonoscopy | 1 | 2023 | 15 | 0.060 |
Why?
| | Face | 1 | 2022 | 3 | 0.060 |
Why?
| | Histone Demethylases | 1 | 2022 | 2 | 0.060 |
Why?
| | Gene Dosage | 1 | 2023 | 8 | 0.060 |
Why?
| | Acute Disease | 1 | 2023 | 71 | 0.060 |
Why?
| | 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2022 | 3 | 0.060 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2022 | 4 | 0.060 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2022 | 7 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2022 | 50 | 0.050 |
Why?
| | GPI-Linked Proteins | 1 | 2021 | 1 | 0.050 |
Why?
| | Hyaluronoglucosaminidase | 1 | 2021 | 2 | 0.050 |
Why?
| | Cell Adhesion Molecules | 1 | 2021 | 4 | 0.050 |
Why?
| | Follow-Up Studies | 1 | 2023 | 315 | 0.050 |
Why?
| | Data Accuracy | 1 | 2021 | 6 | 0.050 |
Why?
| | Reference Values | 1 | 2021 | 40 | 0.050 |
Why?
| | Complement C6 | 1 | 2020 | 4 | 0.050 |
Why?
| | Complement C7 | 1 | 2020 | 4 | 0.050 |
Why?
| | RNA Nucleotidyltransferases | 1 | 2020 | 4 | 0.050 |
Why?
| | TNF Receptor-Associated Factor 3 | 1 | 2020 | 4 | 0.050 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2020 | 4 | 0.050 |
Why?
| | Perforin | 1 | 2020 | 4 | 0.050 |
Why?
| | Scavenger Receptors, Class A | 1 | 2020 | 5 | 0.050 |
Why?
| | GRB2 Adaptor Protein | 1 | 2020 | 5 | 0.050 |
Why?
| | STAT1 Transcription Factor | 1 | 2020 | 6 | 0.050 |
Why?
| | Infant, Extremely Low Birth Weight | 1 | 2021 | 9 | 0.050 |
Why?
| | Toll-Like Receptor 3 | 1 | 2020 | 6 | 0.050 |
Why?
| | DNA-Binding Proteins | 1 | 2020 | 35 | 0.050 |
Why?
| | Pilot Projects | 1 | 2020 | 124 | 0.050 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 1 | 0.050 |
Why?
| | Infant, Premature | 1 | 2021 | 81 | 0.050 |
Why?
| | White Matter | 1 | 2020 | 6 | 0.050 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 145 | 0.040 |
Why?
| | Adenosine Diphosphate | 1 | 2018 | 1 | 0.040 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2018 | 4 | 0.040 |
Why?
| | Finland | 1 | 2018 | 11 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2018 | 5 | 0.040 |
Why?
| | Pakistan | 1 | 2018 | 5 | 0.040 |
Why?
| | Asymptomatic Diseases | 1 | 2018 | 5 | 0.040 |
Why?
| | Phosphorylation | 1 | 2018 | 21 | 0.040 |
Why?
| | Incidental Findings | 1 | 2018 | 8 | 0.040 |
Why?
| | Larva | 1 | 2018 | 1 | 0.040 |
Why?
| | Purkinje Cells | 1 | 2018 | 2 | 0.040 |
Why?
| | Genetic Complementation Test | 1 | 2018 | 4 | 0.040 |
Why?
| | Family | 1 | 2018 | 26 | 0.040 |
Why?
| | Eyelids | 1 | 2018 | 1 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2018 | 3 | 0.040 |
Why?
| | Interferon Regulatory Factors | 1 | 2018 | 4 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2018 | 6 | 0.040 |
Why?
| | Amino Acid Sequence | 1 | 2018 | 27 | 0.040 |
Why?
| | Chromosome Deletion | 1 | 2018 | 14 | 0.040 |
Why?
| | Eye Abnormalities | 1 | 2018 | 5 | 0.040 |
Why?
| | Recurrence | 1 | 2018 | 115 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2018 | 14 | 0.040 |
Why?
| | Muscle Spasticity | 1 | 2018 | 3 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2018 | 33 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2018 | 202 | 0.040 |
Why?
| | Epilepsies, Partial | 1 | 2017 | 5 | 0.040 |
Why?
| | Gene Frequency | 1 | 2018 | 88 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2018 | 150 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2017 | 6 | 0.040 |
Why?
| | Electronic Health Records | 1 | 2018 | 61 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2017 | 30 | 0.040 |
Why?
| | Hematopoietic Stem Cells | 1 | 2017 | 22 | 0.040 |
Why?
| | Cohort Studies | 1 | 2018 | 264 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2017 | 73 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 74 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 92 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 109 | 0.040 |
Why?
| | Spindle Apparatus | 1 | 2016 | 3 | 0.040 |
Why?
| | Molecular Chaperones | 1 | 2016 | 6 | 0.040 |
Why?
| | Risk Factors | 1 | 2018 | 460 | 0.040 |
Why?
| | Protein Binding | 1 | 2016 | 30 | 0.040 |
Why?
| | Age of Onset | 1 | 2016 | 27 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 2016 | 13 | 0.040 |
Why?
| | Cell Proliferation | 1 | 2016 | 55 | 0.040 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 340 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 15 | 0.040 |
Why?
| | Electroencephalography | 1 | 2016 | 6 | 0.040 |
Why?
| | Cricetulus | 1 | 2015 | 1 | 0.030 |
Why?
| | Action Potentials | 1 | 2015 | 3 | 0.030 |
Why?
| | Cricetinae | 1 | 2015 | 3 | 0.030 |
Why?
| | CHO Cells | 1 | 2015 | 3 | 0.030 |
Why?
| | Ion Channel Gating | 1 | 2015 | 3 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 8 | 0.030 |
Why?
| | COS Cells | 1 | 2015 | 17 | 0.030 |
Why?
| | Genetic Markers | 1 | 2015 | 20 | 0.030 |
Why?
| | Embryo, Nonmammalian | 1 | 2015 | 1 | 0.030 |
Why?
| | Zebrafish Proteins | 1 | 2015 | 1 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 2015 | 8 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 14 | 0.030 |
Why?
| | Heart | 1 | 2015 | 15 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 33 | 0.030 |
Why?
| | Chronic Disease | 1 | 2015 | 103 | 0.030 |
Why?
| | Critical Illness | 1 | 2015 | 21 | 0.030 |
Why?
| | Cranial Fontanelles | 1 | 2015 | 1 | 0.030 |
Why?
| | Ultrasonography, Prenatal | 1 | 2015 | 8 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 16 | 0.030 |
Why?
| | Cataract | 1 | 2015 | 1 | 0.030 |
Why?
| | Greenland | 1 | 2015 | 1 | 0.030 |
Why?
| | Atrophy | 1 | 2015 | 6 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 6 | 0.030 |
Why?
| | Movement Disorders | 1 | 2015 | 4 | 0.030 |
Why?
| | Calcium | 1 | 2015 | 36 | 0.030 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 65 | 0.030 |
Why?
| | Neutropenia | 1 | 2015 | 13 | 0.030 |
Why?
| | Health Care Costs | 1 | 2014 | 29 | 0.030 |
Why?
| | Tandem Mass Spectrometry | 1 | 2014 | 19 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2015 | 81 | 0.030 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2014 | 2 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 4 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 2014 | 9 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 46 | 0.030 |
Why?
| | Iron | 1 | 2014 | 13 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2014 | 23 | 0.030 |
Why?
| | Liver | 1 | 2015 | 119 | 0.030 |
Why?
| | Diet | 1 | 2014 | 54 | 0.030 |
Why?
| | Leigh Disease | 1 | 2013 | 1 | 0.030 |
Why?
| | Ubiquinone | 1 | 2013 | 1 | 0.030 |
Why?
| | Electron Transport Complex I | 1 | 2013 | 1 | 0.030 |
Why?
| | Muscle Weakness | 1 | 2013 | 2 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2012 | 12 | 0.030 |
Why?
| | Organ Specificity | 1 | 2012 | 22 | 0.030 |
Why?
| | Connexins | 1 | 2012 | 3 | 0.030 |
Why?
| | Gene Expression | 1 | 2012 | 60 | 0.030 |
Why?
| | Bone Density | 1 | 2012 | 43 | 0.030 |
Why?
| | Absorption | 1 | 2011 | 7 | 0.030 |
Why?
| | Up-Regulation | 1 | 2011 | 25 | 0.030 |
Why?
| | Models, Biological | 1 | 2011 | 46 | 0.020 |
Why?
| | Niacinamide | 1 | 2008 | 1 | 0.020 |
Why?
| | Diuretics | 1 | 2008 | 4 | 0.020 |
Why?
| | Acetazolamide | 1 | 2008 | 2 | 0.020 |
Why?
| | Vitamin B Complex | 1 | 2008 | 2 | 0.020 |
Why?
| | Hip Joint | 1 | 2008 | 4 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 1 | 0.020 |
Why?
| | Molecular Biology | 1 | 2008 | 2 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 16 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2008 | 19 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2007 | 4 | 0.020 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|